Since morbid obesity by itself is not a telltale sign of Cushing’s syndrome, routine screenings for the disease in obese patients referred for weight-loss surgery is unnecessary, a study reported. Published in the journal Pamukkale Tıp Dergisi, the study was titled “Is screening for…
News
People with Cushing’s syndrome experience muscle weakness that persists even when the disorder is in remission, a new study shows. The study, “Persisting muscle dysfunction in Cushing’s syndrome despite biochemical remission,” was published in The Journal of Clinical Endocrinology and Metabolism. Cushing’s syndrome is characterized by…
Patients prefer the overnight dexamethasone suppression test (ONDST) over the 24-hour urine analysis test as a first screening test for Cushing’s syndrome, a study has found. The study, “Preferred screening test for Cushing’s syndrome screening,” was published in the Journal of Endocrinology…
People with Cushing’s syndrome commonly experience cognitive and emotional problems, a new study indicates. The study, “Neuropsychological and Emotional Functioning in Patients with Cushing’s Syndrome,” was published in Behavioural Neurology. Cushing’s syndrome is characterized by abnormally high levels of the hormone cortisol. (Cushing’s disease…
Metopirone Safely Normalized, or Significantly Lowered, Urine Cortisol Levels in Phase 3/4 Trial
Metopirone (metyrapone) safely normalized, or at least lowered by half, the levels of cortisol found in the urine of patients with endogenous Cushing’s syndrome, according to data from a Phase 3/4 clinical trial. Findings from the study, called PROMPT (NCT02297945), were presented recently by…
A combination of bexarotene and lapatinib, two approved anti-cancer medications, may hold promise in treating Cushing’s disease, according to a recent study. The study, “Bexarotene combined with lapatinib for the treatment of Cushing’s disease: evidence based on drug repositioning and experimental confirmation,” was published in the…
Patients with endogenous Cushing’s syndrome who stopped using Recorlev (levoketoconazole) and moved to a placebo in a study started having their urine cortisol levels rise in response to lack of treatment, compared with those who remained on Recorlev, according to top-line data from the Phase 3 LOGICS…
Abnormally high levels of cortisol in the urine — one of the hallmarks of Cushing’s syndrome — seem to be associated with alterations in blood sugar metabolism in obese patients, a study found. The study, “Hypercortisolism and altered glucose homeostasis in obese patients in…
An alternative diagnostic test to measure the levels of late-night cortisol in the saliva of patients with Cushing’s disease did not meet the standards of currently used methods, a study demonstrates. The study, “Prospective evaluation of…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography competition to raise awareness for rare diseases. Under the theme “A Glimmer of Hope,” the competition is a means to “visually express the hope that exists for people affected by…
Recent Posts
- Relacorilant safe, works to control high blood pressure in Cushing’s: Study
- What I wish people understood about living with Cushing’s disease
- New imaging method helps pinpoint tumors in Cushing’s disease
- New case report highlights Cushing’s syndrome after yearlong steroid use
- How my healthcare experience has differed from New York to Michigan
- Pain and body image drive Cushing’s depression more than hormones
- Rare pituitary tumor in sinus cavity caused Cushing’s in woman: Report
- The Cushing’s disease symptoms that creep in when I’m off my meds
- Cushing’s tumor tied to inherited Lynch syndrome: Case study
- AI tools ‘effective’ at predicting remission after Cushing’s surgery